中东和非洲血浆分馏市场预测至 2028 年 - COVID-19 影响和按产品(免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂和其他血浆产品)、应用(神经病学、免疫学、血液学、重症监护、肺病学)进行区域分析和其他应用程序)和最终用户(医院和诊所、临床研究实验室和学术机构)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 123    |    Report Code: TIPRE00026274    |    Category: Life Sciences

Middle East and Africa Plasma Fractionation Market

市场介绍

阿拉伯联合酋长国(UAE)、沙特阿拉伯和南非是MEA 的 3 个主要国家。 2021 年,沙特阿拉伯是该地区最大的血浆分离市场。MEA 的血浆分离市场预计在预测期内将以 5.2% 的复合年增长率增长;这种增长归因于各种疾病患病率的上升以及该地区政府举措的增加。

经济的不确定性和持续的冲突正在使该地区的状况恶化。例如,叙利亚、利比亚和也门等国家正遭受暴力冲突,无法实施强有力的公共卫生措施。由于美国的制裁,伊朗经济陷入严重衰退。此外,中东国家经济稳定的主要来源是石油生产和出口。然而,COVID-19 大流行正在造成中东经济动荡。国内外对商品和产品(特别是原油)的需求突然下降,以及由于劳动力短缺而导致的生产停顿是该地区受到的重大影响。 COVID-19 在该地区的传播给医疗保健专业人员造成了沉重的负担。心脏外科医生不堪重负,需要进行紧急心脏手术、管理 COVID-19 患者以及实施安全指南以防止病毒传播。病毒的迅速传播影响了择期手术。因此,COVID-19 的爆发对 MEA 血浆分离市场的增长产生了负面影响。

 

   

   

市场概况和动态

血浆分离中东和非洲市场预计将从 2021 年的 24.5561 亿美元增长到 2028 年的 34.9073 亿美元;预计 2021 年至 2028 年复合年增长率为 5.2%。血浆是治疗各种慢性疾病的新兴方法之一。血浆由蛋白质、白蛋白、球蛋白、纤维蛋白原、凝血因子和抑制剂等必需成分组成。它广泛用于血癌、新冠肺炎、心房颤动、白血病等。通过血浆分级分离将血浆从捐献的血液中分离出来。监管机构还为在处理过程中使用等离子体提供所需的批准。因此,监管机构和政府的积极参与和批准有望鼓励血浆的应用。献血后 24 小时内冷冻,血浆可保存长达一年,以保护宝贵的凝血因子,并可在解冻后使用。每个国家都建立了许多血库机构,可以利用医疗服务提供者,并由各国政府和其他组织资助。因此,根据上述因素,预测期内血浆分离相关市场。      

主要细分市场

< MEA 血浆分离市场分为产品、应用、最终用户和国家。 MEA 血浆分离市场根据产品分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白细分市场可能会在 2021 年占据最大的市场份额。MEA 血浆分离市场根据应用分为神经病学、免疫学、血液学、重症监护、肺病学等。 2021 年,神经病学领域可能会占据最大的市场份额。 MEA 血浆分离市场根据最终用户分为医院和诊所、临床研究实验室、学术机构。 2021年,医院和诊所部门可能会占据最大的市场份额。根据国家/地区,MEA 血浆分馏市场分为沙特阿拉伯、南非、阿联酋和 MEA 的其他地区。中东和非洲其他地区在 2021 年占据了最大的市场份额。

主要来源和上市公司

准备本中东和非洲血浆分馏市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库,其中其他的。报告中列出的主要公司有 Bharat Serums and Vaccines Limited (BSV);生物制品实验室有限公司;生物测试公司; CSL有限公司;格里福尔斯,SA; Kedrion SpA;奥克塔制药公司;和 SK 等离子。          

原因购买报告

  • 了解 MEA 血浆分馏市场格局并确定最重要的细分市场可能会保证丰厚的回报。
  • 了解 MEA 血浆分馏市场不断变化的竞争格局,保持领先地位。
  • 通过识别最有可能销售的细分市场,有效规划 MEA 血浆分馏市场的并购和合作交易。
  • 帮助从敏锐的洞察力中做出明智的业务决策并对 MEA 血浆分馏市场各个细分市场的市场表现进行综合分析。
  • 获取 MEA 地区 2021-2028 年各个细分市场的市场收入预测。< /span>

MEA

血浆分馏市场

细分

MEA 血浆分馏市场 -

按产品

  • 免疫球蛋白
    • 静脉注射免疫球蛋白(IVIG)
    • 皮下注射免疫球蛋白(SCIG) )
  • 白蛋白
  • 浓缩凝血因子
  • < li>蛋白酶抑制剂
  • 其他

MEA 血浆分馏市场-

申请

  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他

MEA 血浆分馏市场 - 结束用户

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

MEA 血浆分馏市场 - 按国家/地区

  • 沙特阿拉伯
  • 南非
  • 阿联酋
  • MEA其他地区

MEA血浆分馏市场 - 公司简介

  • 巴拉特血清和疫苗有限公司 (BSV)
  • 生物制品实验室有限公司< /li>
  • Biotest AG。
  • CSL Limited
  • Grifols, SA< /li>
  • Kedrion SpA
  • Octapharma AG
  • SK Plasma


Middle East and Africa Plasma Fractionation Strategic Insights

Strategic insights for Middle East and Africa Plasma Fractionation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-plasma-fractionation-market-strategic-framework.webp
Get more information on this report

Middle East and Africa Plasma Fractionation Report Scope

Report Attribute Details
Market size in 2021 US$ 2,455.61 Million
Market Size by 2028 US$ 3,490.73 Million
Global CAGR (2021 - 2028) 5.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 产品
  • 免疫球蛋白
  • 白蛋白
  • 凝血因子浓缩物
  • 蛋白酶抑制剂
  • 其他血浆产品
By 应用
  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他应用
By 最终用户
  • 医院和诊所
  • 临床研究实验室
  • 学术机构
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG.
  • CSL Limited
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma AG
  • SK Plasma
  • Get more information on this report

    Middle East and Africa Plasma Fractionation Regional Insights

    The regional scope of Middle East and Africa Plasma Fractionation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-plasma-fractionation-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East and Africa Plasma Fractionation Market

    1. Bharat Serums and Vaccines Limited (BSV)
    2. Bio Products Laboratory Ltd.
    3. Biotest AG.
    4. CSL Limited
    5. Grifols, S.A.
    6. Kedrion S.p.A
    7. Octapharma AG
    8. SK Plasma
    Frequently Asked Questions
    How big is the Middle East and Africa Plasma Fractionation Market?

    The Middle East and Africa Plasma Fractionation Market is valued at US$ 2,455.61 Million in 2021, it is projected to reach US$ 3,490.73 Million by 2028.

    What is the CAGR for Middle East and Africa Plasma Fractionation Market by (2021 - 2028)?

    As per our report Middle East and Africa Plasma Fractionation Market, the market size is valued at US$ 2,455.61 Million in 2021, projecting it to reach US$ 3,490.73 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Plasma Fractionation Market report typically cover these key segments-

  • 产品 (免疫球蛋白, 白蛋白, 凝血因子浓缩物, 蛋白酶抑制剂, 其他血浆产品)
  • 应用 (神经病学, 免疫学, 血液学, 重症监护, 肺病学, 其他应用)
  • 最终用户 (医院和诊所, 临床研究实验室, 学术机构)
  • What is the historic period, base year, and forecast period taken for Middle East and Africa Plasma Fractionation Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Plasma Fractionation Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East and Africa Plasma Fractionation Market?

    The Middle East and Africa Plasma Fractionation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG.
  • CSL Limited
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma AG
  • SK Plasma
  • Who should buy this report?

    The Middle East and Africa Plasma Fractionation Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Plasma Fractionation Market value chain can benefit from the information contained in a comprehensive market report.